The postdoctoral research training program in Endocrinology and Diabetes at the Massachusetts General Hospital provides intensive research experience in basic or clinical investigation, complemented by a didactic component appropriate to the training goals. The trainees are primarily M.D.'s and M.D./Ph.D.'s who desire a career in investigative endocrinology and academic medicine, as well as Ph.D.'s who want further research training. The trainees are selected from a large applicant pool on the basis of prior academic and/or research achievement, and evidence of strong commitment to a career in biomedical investigation. The Program director (J. Avruch) is a senior academician and endocrine investigator who governs in conjunction with a committee of experienced endocrine scientists (Habener, Kronenberg, Crowley, Neer, Freeman, Grinspoon and Klibanski). The faculty consists of 49 active, well-funded scientists, whose interests range broadly across the subdisciplines of endocrinology, and from clinical, bedside investigation to molecular mechanisms. The trainees are supervised closely by a primary faculty mentor, and interact extensively with junior faculty, who often serve as secondary mentors. An extensive program of didactic sessions complements the research activity. The training period is 2-3 years but may include several years additional experience at junior faculty status, so as to permit consolidation of skills and maximal competitiveness for independent support. The productivity of past trainees during training has been very high overall, as judged by the number and quality of trainee publications. The majority of program graduates remain in academia and a substantial number are in the biotechnology/pharmaceutical industry. Among those in academia, about one fifth of graduates since 1999 have an RO-1 and about two fifths have achieved transitional independent support, a usual precursor to RO-1 support. The facilities at the MGH are extensive, including an Institutional Clinical Research Support Program and over 50,000 square feet of modern laboratories dedicated to endocrine training faculty. This training grant is the central stabilizing financial element in this program, and is especially critical in enabling M.D. trainees to achieve careers in biomedical investigation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK007028-40
Application #
8695324
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Castle, Arthur
Project Start
1975-07-01
Project End
2015-06-30
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
40
Fiscal Year
2014
Total Cost
$651,745
Indirect Cost
$49,450
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Chan, Yee-Ming; Lippincott, Margaret F; Kusa, Temitope O et al. (2018) Divergent responses to kisspeptin in children with delayed puberty. JCI Insight 3:
Fourman, Lindsay T; Czerwonka, Natalia; Shaikh, Sofia D et al. (2018) Insulin-like growth factor 1 inversely relates to monocyte/macrophage activation markers in HIV. AIDS 32:927-932
Karaca, Anara; Malladi, Vijayram Reddy; Zhu, Yan et al. (2018) Constitutive stimulatory G protein activity in limb mesenchyme impairs bone growth. Bone 110:230-237
Devlin, M J; Robbins, A; Cosman, M N et al. (2018) Differential effects of high fat diet and diet-induced obesity on skeletal acquisition in female C57BL/6J vs. FVB/NJ Mice. Bone Rep 8:204-214
Dichtel, Laura E; Bjerre, Mette; Schorr, Melanie et al. (2018) The effect of growth hormone on bioactive IGF in overweight/obese women. Growth Horm IGF Res 40:20-27
Cox, Kimberly H; Oliveira, Luciana M B; Plummer, Lacey et al. (2018) Modeling mutant/wild-type interactions to ascertain pathogenicity of PROKR2 missense variants in patients with isolated GnRH deficiency. Hum Mol Genet 27:338-350
Yang, Xuehui; Gong, Yan; He, Qing et al. (2018) Loss of Spry1 attenuates vascular smooth muscle proliferation by impairing mitogen-mediated changes in cell cycle regulatory circuits. J Cell Biochem 119:3267-3279
Dichtel, Laura E; Lawson, Elizabeth A; Schorr, Melanie et al. (2018) Neuroactive Steroids and Affective Symptoms in Women Across the Weight Spectrum. Neuropsychopharmacology 43:1436-1444
Foldyna, Borek; Fourman, Lindsay T; Lu, Michael T et al. (2018) Sex Differences in Subclinical Coronary Atherosclerotic Plaque Among Individuals With HIV on Antiretroviral Therapy. J Acquir Immune Defic Syndr 78:421-428
Cheru, Lediya T; Fitch, Kathleen V; Saylor, Charles F et al. (2018) Mild renal impairment is associated with calcified plaque parameters assessed by CT angiography in people living with HIV. AIDS :

Showing the most recent 10 out of 169 publications